{"denoms":[{"counts":[{"groupId":"BG000","value":"25"}],"units":"Participants"}],"groups":[{"description":"rituximab\n\ncytarabine\n\ndexamethasone\n\nleucovorin calcium\n\nmethotrexate\n\nprocarbazine hydrochloride\n\nvincristine sulfate","id":"BG000","title":"Rituximab + Standard Chemotherapy"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"15"}],"title":"Age < 60 years"},{"measurements":[{"groupId":"BG000","value":"10"}],"title":"Age ≥ 60 years"}],"title":"Age"}],"description":"Older or younger than 60","paramType":"COUNT_OF_PARTICIPANTS","title":"Age, Customized","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"15"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"10"}],"title":"Male"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"24"}],"title":"White"},{"measurements":[{"groupId":"BG000","value":"1"}],"title":"Asian"}],"title":"Race"}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Race/Ethnicity, Customized","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"25"}]}],"title":"United States"}],"paramType":"NUMBER","title":"Region of Enrollment","unitOfMeasure":"participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"1"}],"title":"0"},{"measurements":[{"groupId":"BG000","value":"15"}],"title":"1"},{"measurements":[{"groupId":"BG000","value":"5"}],"title":"2"},{"measurements":[{"groupId":"BG000","value":"4"}],"title":"3"}]}],"description":"0 = Fully active, able to carry on all pre-disease performance without restriction\n\n1. = Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work\n2. = Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours\n3. = Capable of only limited selfcare; confined to bed or chair more than 50% of waking hours\n4. = Completely disabled; cannot carry on any selfcare; totally confined to bed or chair","paramType":"COUNT_OF_PARTICIPANTS","title":"ECOG Performance Status","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"0"}],"title":"No symptoms"},{"measurements":[{"groupId":"BG000","value":"11"}],"title":"Minor symptoms"},{"measurements":[{"groupId":"BG000","value":"5"}],"title":"Moderate symptoms/fully active"},{"measurements":[{"groupId":"BG000","value":"7"}],"title":"Moderate symptoms/less than fully active"},{"measurements":[{"groupId":"BG000","value":"2"}],"title":"Severe neurologic symptoms"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Neurologic Function Status","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"21"}],"title":"Never"},{"measurements":[{"groupId":"BG000","value":"4"}],"title":"Symptomatic or on medication"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Cerebrovascular Disease","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"9"}],"title":"Never"},{"measurements":[{"groupId":"BG000","value":"7"}],"title":"Symptomatic or on medication"},{"measurements":[{"groupId":"BG000","value":"7"}],"title":"Past history of"},{"measurements":[{"groupId":"BG000","value":"2"}],"title":"Missing/unknown"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Other Medical Problems at Baseline","unitOfMeasure":"Participants"}],"populationDescription":"Eligible patients who began protocol therapy"}